Topic: computational biology

Converge Bio Secures $25M From Bessemer, Meta, OpenAI, Wiz Execs

Converge Bio, a startup specializing in AI for drug discovery, secured $25 million in Series A funding led by Bessemer Venture Partners, with backing from major tech executives. The company uses generative AI trained on molecular data to provide integrated systems for the entire drug development ...